Compass Therapeutics Inc. (CMPX) Live Share Price, Invest From India

Compass Therapeutics Inc. Stock Performance

as on May 8, 2026 at 1:08 am IST

Day's Low
Day's High
$1.78
Day's Price Range
$1.87
$1.79
0.56%
Downside
4.47%
Upside
52 Week's Low
52 Week's High
$1.61
52-Week Price Range
$6.88
$1.79
10.06%
Downside
284.36%
Upside

Compass Therapeutics Inc. share price movements today

Previous Close: $1.87
Open: $1.85
Volume: 1.3M
Day's Low - High: $1.78 - $1.87
52 Week Low - High: $1.61 - $6.88

Compass Therapeutics Inc. Historical Returns

1 Month Return: -64.78 %
3 Month Return: -71.32 %
1 Year Return: + 6.25 %
3 Year Return: -43.5 %
5 Year Return: 0 %

Compass Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Compass Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$351.2M

EPS (TTM)

-0.425

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-72.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-41.29%

Compass Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Compass Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Compass Therapeutics Inc.	BUY	$351.2M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.5B	130.77%	76.32	12.55%
BeiGene, Ltd.	NA	$32.5B	NA	70.89	5.37%
Vertex Pharmaceuticals Inc	BUY	$108.5B	98.9%	25.38	35.51%
Regeneron Pharmaceuticals Inc	BUY	$75.6B	45.15%	17.6	29.65%

Stock Returns calculator for Compass Therapeutics Inc. Stock including INR - Dollar returns

The Compass Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Compass Therapeutics Inc. investment value today

Current value as on today

₹1,13,131

Returns

₹13,131

(+13.13%)

Returns from Compass Therapeutics Inc. Stock

₹1,705 (+1.7%)

Dollar Impact

₹11,427 (+11.43%)

Analyst Recommendation on Compass Therapeutics Inc. Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Compass Therapeutics Inc.. Average target price of $11.17

Compass Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Compass Therapeutics Inc..

What analysts predicted

83.97%UPSIDE

Target Price

$11.17

Current Price

$1.79

Analyzed by

13 Analysts

Target

$11.17

Compass Therapeutics Inc. target price $11.17, a slight upside of 83.97% compared to current price of $1.79. According to 13 analysts rating.

Indian Investors' Interest in Compass Therapeutics Inc. Stock

Search interest for Compass Therapeutics Inc. Stock has increased by 1448% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 7, 2026 to May 7, 2026

Change:1448% versus previous 30 day period

Compass Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	2	-	0	-	-	-	-	-	-
Gross Profit	0	2	0	0	-	-	-	0	-	-
Operating Income	-11	-15	-12	-15	-12	-16	-17	-21	-15	-17
EBITDA	-11	-15	-12	-14	-11	-16	-17	-20	-14	-
Interest Expense	-	1	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-9	-13	-10	-13	-10	-15	-16	-19	-14	-15
Income Tax Expense	0	1	0	-	-	-	-	-	-	-
Net Income	-9	-13	-10	-13	-10	-15	-16	-19	-14	-15
Net Profit Margin	0.00%	-471.69%	0.00%	-1538.35%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compass Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	0	-
Gross Profit	-1	-2	-2	-1	-1	-1	0	-
Operating Income	-38	-34	-27	-81	-41	-50	-56	-72
EBITDA	-35	-31	-25	-80	-39	-48	-54	-72
Interest Expense	0	1	0	0	2	-	-	-
Depreciation	1	2	2	1	1	1	1	1
Income Before Tax	-38	-34	-29	-82	-39	-42	-49	-66
Income Tax Expense	0	0	0	0	-2	-	-	-
Net Income	-38	-34	-29	-82	-39	-42	-49	-66
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-5808.82%	0.00%

Compass Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-13	-10	-13	-10	-15	-16	-19	-14	-15
Operating Cash Flow	-12	-13	-10	-11	-9	-13	-11	-10	-13
Investing Cash Flow	6	-4	6	29	15	11	-6	-95	-3
Financing Cash Flow	0	17	0	0	0	0	-	129	1
Change in Cash	-6	0	-4	17	6	-2	-18	23	-15

Compass Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-34	-29	-82	-39	-42	-49	-66
Operating Cash Flow	-31	-26	-19	-34	-40	-44	-49
Investing Cash Flow	0	0	-1	-151	26	46	-93
Financing Cash Flow	0	48	118	75	2	17	129
Change in Cash	-32	21	97	-109	-10	19	-12

Global Institutional Holdings in Compass Therapeutics Inc.

Funds	Holdings
Vanguard Group Inc	4.47%
Bvf Inc	4.31%
Blackstone Inc	3.4%
Enavate Sciences GP, LLC	4.38%
Rock Springs Capital Management LP	2.18%

See all

Insights on Compass Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 34.9% return, outperforming this stock by 28.6%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 68.9%
NEGATIVE IMPACT
Price Dip
In the last 1 month, CMPX stock has moved down by -64.8%

About Compass Therapeutics Inc.

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidate, tovecimig, is a bispecific antibody that targets delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A), which are critical to angiogenesis and tumor vascularization. It also develops CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells; CTX-8371, a bispecific inhibitor that targets programmed cell death protein-1 (PD-1) and ligand PD-L1 checkpoint inhibitor antibodies; and CTX-10726, a bispecific antibody that targets PD-1 and VEFG-A. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Organisation	Compass Therapeutics Inc.
Headquarters	80 Guest Street, Boston, MA, United States, 02135
Industry	Biotechnology
CEO	Dr. Thomas J. Schuetz M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Compass Therapeutics Inc.

Name	Title
Dr. Thomas J. Schuetz M.D., Ph.D.	CEO & Vice Chairman
Mr. Barry Shin J.D., M.B.A.	Chief Financial Officer
Mr. Jonathan E. Anderman J.D.	Senior VP, General Counsel & Corporate Secretary
Mr. Bing Gong Ph.D.	Chief Scientific Officer
Ms. Karin Herrera B.A.	Senior VP & Head of Clinical Operations
Dr. James Kranz Ph.D.	VP and Head of Chemistry Manufacturing & Controls
Dr. Cynthia A. Sirard M.D., Ph.D.	Chief Medical Officer
Mr. Arjun Prasad M.B.A., M.P.H.	Chief Commercial Officer

FAQs

What is Compass Therapeutics Inc. share price today?

Compass Therapeutics Inc. share price today is $1.79 as on May 7, 2026 at 7:38 pm IST. Compass Therapeutics Inc. share today touched a day high of $1.87 and a low of $1.78.

What is the 52 week high and 52 week low for Compass Therapeutics Inc. share?

Compass Therapeutics Inc. share touched a 52 week high of $6.88 on February 3, 2026 and a 52 week low of $1.61 on April 27, 2026. Compass Therapeutics Inc. stock price today i.e. May 7, 2026 at 7:38 pm IST is trending at $1.79,which is 73.98% down from its 52 week high and 11.18% up from its 52 week low.

What is Compass Therapeutics Inc.'s market capitalisation today?

Compass Therapeutics Inc. market capitalisation is $0.00T as on May 7, 2026 at 7:38 pm IST.

How to invest in Compass Therapeutics Inc. Stock (CMPX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Compass Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Compass Therapeutics Inc. Shares that will get you 0.8380 shares as per Compass Therapeutics Inc. share price of $1.79 per share as on May 7, 2026 at 7:38 pm IST.

What is the minimum amount required to buy Compass Therapeutics Inc. Stock (CMPX) from India?

Indian investors can start investing in Compass Therapeutics Inc. (CMPX) shares with as little as ₹94.24 or $1 (as of May 7, 2026 at 7:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Compass Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on May 7, 2026 at 7:38 pm IST). Based on Compass Therapeutics Inc. share’s latest price of $1.79 as on May 7, 2026 at 7:38 pm IST, you will get 5.5866 shares of Compass Therapeutics Inc.. Learn more about fractional shares .